Compounds of formula (I) or salts thereof, wherein A, and R.sup.1 to R.sup.5 are as defined in the specification, are DGAT-1 inhibitors and are thereby useful in the treatment of, for example, obesity. Processes to make compounds of formula (I) are also described. ##STR00001##

 
Web www.patentalert.com

< 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors

< Inhibitors of Akt activity

> Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation

> Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones

~ 00620